{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:08:23Z","timestamp":1761505703530,"version":"build-2065373602"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.cllc.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T14:04:54Z","timestamp":1408111494000},"page":"6-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multimodality Treatment With Surgery for Locally Advanced Non\u2013Small-Cell Lung Cancer With N2 Disease: A Review Article"],"prefix":"10.1016","volume":"16","author":[{"given":"Gouji","family":"Toyokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Takenoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukito","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2014.07.007_bib1","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.12-2377","article-title":"Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Detterbeck","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2014.07.007_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non\u2013small-cell lung cancer. Lung Cancer Study Group","volume":"60","author":"Ginsberg","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JTO.0b013e31815e8577","article-title":"A\u00a0Japanese lung cancer registry study: prognosis of 13,010 resected lung cancers","volume":"3","author":"Asamura","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.lungcan.2005.05.021","article-title":"Prognosis of 6644 resected non\u2013small-cell lung cancers in Japan: a Japanese lung cancer registry study","volume":"50","author":"Goya","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/JTO.0b013e318219aae2","article-title":"Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade","volume":"6","author":"Sawabata","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa032792","article-title":"A\u00a0randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung","volume":"350","author":"Kato","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2014.07.007_bib7","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib8","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jtcvs.2012.03.039","article-title":"Adjuvant chemotherapy for surgically resected non\u2013small-cell lung cancer","volume":"144","author":"Heon","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib9","first-page":"CD007309","article-title":"Chemotherapy and supportive care versus supportive care alone for advanced non\u2013small-cell lung cancer","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cllc.2014.07.007_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non\u2013small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib11","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","volume":"368","author":"Shaw","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2014.07.007_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S1470-2045(13)70142-6","article-title":"CH5424802 (RO5424802) for patients with ALK-rearranged advanced non\u2013small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study","volume":"14","author":"Seto","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)37318-0","article-title":"Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung","volume":"83","author":"Pearson","year":"1982","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0039-6109(16)44341-0","article-title":"The role of surgery in N2 lung cancer","volume":"67","author":"Martini","year":"1987","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.cllc.2014.07.007_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0003-4975(91)90797-T","article-title":"Aggressive surgical intervention in N2 non\u2013small-cell cancer of the lung","volume":"51","author":"Watanabe","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib16","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0022-5223(19)33901-7","article-title":"The role of mediastinoscopic biopsy in preoperative assessment of lung cancer","volume":"104","author":"Funatsu","year":"1992","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199401203300301","article-title":"A\u00a0randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non\u2013small-cell lung cancer","volume":"330","author":"Rosell","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2014.07.007_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0169-5002(99)00045-8","article-title":"Preresectional chemotherapy in stage IIIA non\u2013small-cell lung cancer: a 7-year assessment of a randomized controlled trial","volume":"26","author":"Rosell","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(98)00046-4","article-title":"Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non\u2013small-cell lung cancer","volume":"21","author":"Roth","year":"1998","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jnci\/86.9.673","article-title":"A\u00a0randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non\u2013small-cell lung cancer","volume":"86","author":"Roth","year":"1994","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2014.07.007_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non\u2013small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2014.07.007_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0360-3016(02)02943-7","volume":"54","author":"Johnstone","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.07.007_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.lungcan.2005.04.001","article-title":"A\u00a0randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non\u2013small-cell lung cancer","volume":"49","author":"Stephens","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/djk093","article-title":"Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non\u2013small-cell lung cancer","volume":"99","author":"van Meerbeeck","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2014.07.007_bib25","doi-asserted-by":"crossref","first-page":"e314S","DOI":"10.1378\/chest.12-2360","article-title":"Treatment of stage III non\u2013small-cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Ramnath","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2014.07.007_bib26","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.2000.18.16.2981","article-title":"Survival of patients with resected N2 non\u2013small-cell lung cancer: evidence for a subclassification and implications","volume":"18","author":"Andre","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mtc.2001.116473","article-title":"Completely resected stage IIIA non\u2013small-cell lung cancer: the significance of primary tumor location and N2 station","volume":"122","author":"Ichinose","year":"2001","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5223(99)70153-4","article-title":"The prognosis of surgically resected N2 non\u2013small-cell lung cancer: the importance of clinical N status","volume":"118","author":"Suzuki","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"suppl 2","key":"10.1016\/j.cllc.2014.07.007_bib29","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0169-5002(10)80005-4","article-title":"Combined modality treatment for stage III non\u2013small-cell lung cancer","volume":"12","author":"Bonomi","year":"1995","journal-title":"Lung Cancer"},{"issue":"suppl 2","key":"10.1016\/j.cllc.2014.07.007_bib30","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0169-5002(10)80004-2","article-title":"Neoadjuvant (induction) treatment for non\u2013small-cell lung cancer","volume":"12","author":"Ginsberg","year":"1995","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jtcvs.2010.02.018","article-title":"Which patients should be operated on after induction chemotherapy for N2 non\u2013small-cell lung cancer? Analysis of a 7-year experience in 175 patients","volume":"140","author":"Stefani","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejcts.2009.04.013","article-title":"Surgical multimodality treatment for baseline resectable stage IIIA-N2 non\u2013small-cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival","volume":"36","author":"Decaluwe","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib33","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0003-4975(98)01187-4","article-title":"Short-course induction chemoradiotherapy with paclitaxel for stage III non\u2013small-cell lung cancer","volume":"66","author":"Rice","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ejcts.2005.02.035","article-title":"Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC","volume":"27","author":"Pezzetta","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejcts.2006.03.054","article-title":"Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer","volume":"30","author":"Takeda","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.athoracsur.2006.02.061","article-title":"Pneumonectomy after high-dose radiation and concurrent chemotherapy for non\u2013small-cell lung cancer","volume":"82","author":"Daly","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jtcvs.2006.12.039","article-title":"Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non\u2013small-cell lung cancer","volume":"133","author":"Yokomise","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib38","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.athoracsur.2009.03.068","article-title":"Trimodal therapy for histologically proven N2\/3 non\u2013small-cell lung cancer: mid-term results and indicators for survival","volume":"87","author":"Steger","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib39","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/cncr.24492","article-title":"Outcomes of patients with stage III non\u2013small-cell lung cancer treated with chemotherapy and radiation with and without surgery","volume":"115","author":"Caglar","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1245\/s10434-009-0810-0","article-title":"Pneumonectomy after neoadjuvant chemotherapy and radiation for advanced-stage lung cancer","volume":"17","author":"Ng","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.athoracsur.2009.04.102","article-title":"Pneumonectomy after chemoradiation therapy for non\u2013small-cell lung cancer: does \u201cside\u201d really matter?","volume":"88","author":"Kim","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib42","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jtcvs.2010.02.039","article-title":"Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non\u2013small-cell lung cancer","volume":"139","author":"Weder","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib43","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.athoracsur.2013.06.036","article-title":"Preoperative concurrent chemoradiotherapy of S-1\/cisplatin for stage III non\u2013small-cell lung cancer","volume":"96","author":"Yamaguchi","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib44","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","article-title":"Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non\u2013small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805","volume":"13","author":"Albain","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib45","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1200\/JCO.1997.15.2.712","article-title":"Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non\u2013small-cell lung cancer","volume":"15","author":"Choi","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-5002(97)00658-2","article-title":"Neoadjuvant therapy for surgically staged IIIA N2 non\u2013small-cell lung cancer (NSCLC)","volume":"17","author":"Elias","year":"1997","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2004.06.004","article-title":"Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non\u2013small-cell lung cancer: final results of the Toronto phase II trial","volume":"47","author":"Burkes","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib48","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.athoracsur.2008.06.022","article-title":"Phase I\/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer","volume":"86","author":"Edelman","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib49","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2008.21.7810","volume":"28","author":"Friedel","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib50","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(08)70156-6","article-title":"Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non\u2013small-cell lung cancer","volume":"9","author":"Thomas","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib51","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/JTO.0b013e31824c945b","article-title":"Surgical outcome of stage IIIA- cN2\/pN2 non\u2013small-cell lung cancer patients in Japanese lung cancer registry study in 2004","volume":"7","author":"Yoshino","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib52","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/JTO.0b013e31828f68b4","article-title":"Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non\u2013small-cell lung cancer","volume":"8","author":"Koshy","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib53","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1378\/chest.07-1360","article-title":"Noninvasive staging of non\u2013small-cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition)","volume":"132","author":"Silvestri","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2014.07.007_bib54","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2007.13.9550","volume":"26","author":"Dooms","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0022-5223(99)70059-0","article-title":"The current role of mediastinoscopy in the evaluation of thoracic disease","volume":"118","author":"Hammoud","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib56","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jtcvs.2011.08.037","article-title":"A\u00a0prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer","volume":"142","author":"Yasufuku","year":"2011","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib57","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/S1470-2045(11)70407-7","article-title":"Mediastinal staging of lung cancer: novel concepts","volume":"13","author":"Tournoy","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib58","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2009.24.5050","article-title":"Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non\u2013small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib59","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjc.6601624","article-title":"Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non\u2013small-cell lung cancer","volume":"90","author":"Katayama","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2014.07.007_bib60","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/JTO.0b013e3182307e5a","article-title":"S-1 plus cisplatin with concurrent radiotherapy for locally advanced non\u2013small-cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706)","volume":"6","author":"Ichinose","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib61","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.athoracsur.2005.02.091","article-title":"Pulmonary resection after high-dose and\u00a0low-dose chest irradiation","volume":"80","author":"Cerfolio","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijrobp.2011.11.069","volume":"84","author":"Suntharalingam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.07.007_bib63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2011.06.1991","article-title":"A\u00a0Phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non\u2013small-cell lung cancer: WJTOG 3305","volume":"83","author":"Tada","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.07.007_bib64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2004.06.260","article-title":"Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non\u2013small-cell lung carcinoma","volume":"61","author":"Bradley","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.07.007_bib65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2010.02.007","article-title":"Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non\u2013small-cell lung cancer (NSCLC): a comparative analysis of toxicities and clinical outcomes","volume":"95","author":"Fernandes","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib66","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/JTO.0b013e318229407f","article-title":"Surgery after induction chemotherapy or chemoradiotherapy for locally advanced lung cancer: a technical challenge","volume":"6","author":"Asamura","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib67","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/JTO.0b013e318228a0d8","article-title":"Contemporary results of surgical resection of non\u2013small-cell lung cancer after induction therapy: a review of 549 consecutive cases","volume":"6","author":"Barnett","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib68","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.athoracsur.2013.02.044","article-title":"Does pneumonectomy have a role in the treatment of stage IIIA non\u2013small-cell lung cancer?","volume":"95","author":"Shah","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib69","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.athoracsur.2009.05.084","article-title":"The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy","volume":"88","author":"Milman","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib70","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/ejcts\/ezr184","article-title":"Sleeve lobectomy after induction chemoradiotherapy","volume":"41","author":"Gomez-Caro","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ejcts\/ezr291","article-title":"Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy","volume":"42","author":"Storelli","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2014.07.007_bib72","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2010.29.1609","article-title":"Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non\u2013small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214","volume":"29","author":"Gore","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.cllc.2014.07.007_bib74","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","article-title":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies","volume":"18","author":"Lipson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.cllc.2014.07.007_bib75","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1200\/JCO.2012.45.6095","article-title":"Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives","volume":"31","author":"Mazieres","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.07.007_bib76","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/nm.3352","article-title":"Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer","volume":"19","author":"Vaishnavi","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cllc.2014.07.007_bib77","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2014.07.007_bib78","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non\u2013small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730414001491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730414001491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:04:15Z","timestamp":1761505455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730414001491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1525730414001491"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2014.07.007","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality Treatment With Surgery for Locally Advanced Non\u2013Small-Cell Lung Cancer With N2 Disease: A Review Article","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}